(Q30304020)

16 June 2017

title

Radiation enhancement by 9-aminocamptothecin: the effect of fractionation and timing of administration (English)

1 reference

16 June 2017

Kirichenko AV

1

1 reference

16 June 2017

Rich TA

series ordinal

2

1 reference

16 June 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

16 June 2017

number of pages

6

1 reference

International Journal of Radiation Oncology Biology Physics

inferred from page(s)

published in

1 reference

16 June 2017

volume

44

1 reference

16 June 2017

issue

3

1 reference

16 June 2017

page(s)

659-664

1 reference

Radiation lethality enhancement with 9-aminocamptothecin: comparison to other topoisomerase I inhibitors

16 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

DNA topoisomerase I and II in cancer chemotherapy: update and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

Apoptotic cell death triggered by camptothecin or teniposide. The cell cycle specificity and effects of ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

DNA damaging and cell cycle effects of the topoisomerase I poison camptothecin in irradiated human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

Schedule-dependent efficacy of camptothecins in models of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

The current status of irinotecan (CPT-11) in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

The effect of proliferative status and clonogen content on the response of mouse jejunal crypts to split-dose irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900062-0

7 January 2021

10.1016/S0360-3016(99)00062-0

Identifiers

DOI

1 reference

16 June 2017

1 reference